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Drosophila melanogaster has proved to be a powerful 
genetic model to decipher the innate immune responses 
to bacterial, fungal and viral infections1. More recently, 
D. melanogaster has emerged as an equally powerful 
model to study host–microorganism interactions in the 
gut2–4. This is due, in part, to the natural ecology of 
the fruitfly: it feeds on microorganisms that develop in 
and live on decaying matter, mostly fruits. Therefore, 
D.  melanogaster ingests the diverse and abundant 
microorganisms that can occupy this environment, and 
transmits them to new habitats. Some of these micro­
organisms, especially yeast species, have well­established 
roles as food5–7. The bacterial species that are most com­
monly associated with D. melanogaster are thought to 
constitute the normal gut microbiota, and a few less 
commonly associated microorganisms have been shown 
to be pathogenic in laboratory settings. Although the 
lines separating these categories are not entirely clear, 
especially in differentiating between the gut microbiota 
and dietary microorganisms, it has been suggested that 
the interactions with these microorganisms have shaped 
D. melanogaster evolution8–11. As a result, D. melano­
gaster exhibits a range of both gut­specific and systemic 
immune responses that help to combat infection. In 
addition, the species possesses mechanisms that main­
tain intestinal tissue homeostasis by both dampening 
gut immune responses to non­pathogenic microorgan­
isms and promoting regeneration of the tissue following 
intestinal damage.
Our understanding of the gut epithelial response 
to indigenous and infectious bacteria has been greatly 
expanded by an increased knowledge of D. melanogaster 
gut structure and function12 (BOX 1), as well as by the 
recent identification of both commensal bacterial species 
associated with the D. melanogaster gut, and pathogens 
that can infect and damage the gut when ingested, such 
as Erwinia carotovora subsp. carotovora 15  (REF. 13), 
Pseudomonas entomophila14 and Serratia marcescens15. 
To date, no specific mechanism to recognize commensal 
bacteria has been identified in D. melanogaster. Despite 
the fact that indigenous and pathogenic microorganisms 
activate similar mechanisms, the level of the immune 
response that is activated, as well as the amount of dam­
age that is inflicted on the gut epithelium, is significantly 
lower in the case of the gut microbiota16. This indicates 
that D. melanogaster has evolved regulatory mechanisms 
that prevent a deleterious induction of the immune 
response under basal conditions, but allow a rapid 
elimination of microorganisms on pathogenic infection.
In this Review, we describe the range of interactions 
between host and bacteria in the D. melanogaster gut, 
as revealed by recent studies. We discuss how the gut 
microbiota affects host physiology, as well as the mecha­
nisms used by D. melanogaster to limit microbial infec­
tion while ensuring intestinal homeostasis, and what 
occurs when these responses are dysregulated.
The microbiota promotes host homeostasis
D. melanogaster feeds on microorganisms that grow in 
overripe and decaying fruit, and thus is constantly exposed 
to dietary and environmental microorganisms. Recently, 
several studies have used 16S rRNA analysis to determine 
the diversity of bacteria commonly associated with D. mel­
anogaster17–22. A major goal of these studies has been to 
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Abstract | Intestinal homeostasis is achieved, in part, by the integration of a complex set of 
mechanisms that eliminate pathogens and tolerate the indigenous microbiota. Drosophila 
melanogaster feeds on microorganism-enriched matter and therefore has developed 
efficient mechanisms to control ingested microorganisms. Regulatory mechanisms ensure  
an appropriate level of immune reactivity in the gut to accommodate the presence of 
beneficial and dietary microorganisms, while allowing effective immune responses to clear 
pathogens. Maintenance of D. melanogaster gut homeostasis also involves regeneration of 
the intestine to repair damage associated with infection. Entomopathogenic bacteria have 
developed common strategies to subvert these defence mechanisms and kill their host.
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define the core microbiome of this species. Collectively, 
these studies, which examined both wild­caught and labo­
ratory fly stocks, indicate that the D. melano gaster gut is 
an environment of low bacterial diversity (1–30 species) 
and that the most commonly associated bacterial species 
are members of the Lactobacillus and Acetobacter genera. 
However, these bacteria also grow in and on the food sub­
strates of the fly (fruit in nature and an artificial diet in the 
laboratory), and it is not fully understood how transient 
these bacterium–fruitfly associations are or whether a 
microbiota is actively growing and maintained in the gut 
(see REF. 23 for further discussion). What is evident is that 
D. melano gaster associates with a narrow range of bacteria 
that is transmitted to new environments through regurgi­
tation or defecation and can be acquired by larvae through 
ingestion of contaminated embryo surfaces or fruit 
tissue. Furthermore, these bacteria are not essential for 
host development or survival, as axenic fly cultures (pro­
duced by decontaminating the embryo surface with 
bleach) can be easily maintained on an adequate diet in 
the laboratory for generations24.
The ability to derive axenic fly lines and thus estab­
lish gnotobiotic cultures has allowed researchers to 
investigate the effects of the gut microbiota and dietary 
microorganisms on D. melanogaster (with the caveat that 
observed differences could be due to direct effects on the 
gut, on the fly medium, or on both). As a result, a growing 
number of studies are showing that the D. melanogaster 
microbiota can influence several attributes of host physi­
ology both locally, by changing intestinal homeostasis, 
and systemically, by modulating host physiology as a 
whole. The gut of axenic flies displays a lower mitotic index 
than that of flies with a gut microbiota16,25, suggesting that 
this microbiota basally stimulates intestinal turnover and 
helps to establish basal tissue homeostasis.
It has also been observed that changes in diet (high 
sugar versus high starch) that shift the composition of 
the gut microbiota affect mating preference, possibly by 
altering the levels of cuticular hydrocarbon sex phero­
mones26. In addition, D. melanogaster larvae that lack a 
gut microbiota are more susceptible than wild­type flies 
to infection with Candida albicans, highlighting a role for 
the microbiota in host defence27. This effect of the micro­
biota is also seen in immunodeficient flies, suggesting 
that the protective effect of the gut microbiota is through 
its impact on other aspects of host physiology (rather 
than the immune system) or through direct competition 
with pathogens27. For example, the gut microbiota might 
help to protect the host by inducing stress and tolerance 
mechanisms or altering the gut physiology to create a 
more inhospitable gut environment (through changes 
in pH and levels of digestive enzymes). Alternatively, the 
gut microbiota might limit the persistence of pathogens 
in the gut or the food substrate by physically occupying 
available niches, outcompeting for available resources, 
or producing antimicrobials. Indeed, studies have shown 
that the presence of larvae in the substrate reduces the 
diversity of dietary yeast species28 and limits the growth 
of pathogenic fungi29. It remains unclear how this is 
achieved and whether the gut microbiota contributes to 
these interactions.
Box 1 | The gut of Drosophila melanogaster
A structured organ
The Drosophila melanogaster gut has a structure and organization that resemble those 
of the mammalian gut. It is a tubular epithelium composed of a monolayer of cells 
surrounded by visceral muscles and tracheae112. This tube is divided into three distinct 
compartments defined by their developmental origin: the foregut, midgut and hindgut 
(see the figure). Both the foregut and hindgut originate from the ectoderm, whereas the 
midgut originates from the endoderm. A layer of cuticle lines the foregut and hindgut.  
In the midgut, a semipermeable chitinous layer, the peritrophic matrix, protects the 
epithelium from physical damage and regulates the passage of particles between the 
lumen and enterocytes. The foregut is subdivided into the pharynx, the oesophagus and 
a diverticulum called the crop, which stores food. The midgut extends from the cardia  
(a valve located at the midgut–foregut junction) to the junction with the hindgut, where 
the Malpighian tubules (the principal excretory and osmoregulatory organ) connect  
to the gut. The midgut is the main site of digestion, and nutrients are absorbed in the 
midgut and hindgut. The midgut is compartmentalized into regions with distinct 
histological and physiological properties12. Despite the important role of the gut in 
digestion and physiology, the mechanisms that control these processes are largely 
unknown.
A dynamic organ
The gut of D. melanogaster, despite its apparent simplicity, is a complex and dynamic 
organ. One specific feature of the adult gut is that it is renewed constantly throughout 
the lifespan of the fly. The adult midgut is composed of two types of cells: large 
absorptive enterocytes (Ecs) and small secretory enteroendocrine cells (Ees). Like the 
mammalian digestive tract, the fly gut epithelium is maintained by pluripotent intestinal 
stem cells (ISCs) that divide and self-renew, giving rise to two cells: a new ISC and a 
progenitor cell, called the enteroblast (Eb), which is devoid of mitotic capability113,114. 
Enteroblasts are maintained transiently in the epithelium or differentiate into either 
enterocytes or enteroendocrine cells115.
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To date, the most consistent effect of the gut micro­
biota on host physiology has been linked to larval 
growth. It has been known for some time that larvae 
raised in axenic conditions exhibit a delay in develop­
ment compared with gnotobiotic or conventionally 
reared larvae24 (for an extensive review, see REF. 23). More 
recently, three independent studies have further charac­
terized this effect of the D. melanogaster gut microbiota 
on larval growth. They found that, although this effect is 
more pronounced in conditions of nutrient scarcity25,30, 
axenic larvae reared on a fully adequate diet also show 
delayed development31. This growth effect depends on 
insulin signalling25,30.
Interestingly, two studies demonstrated that dif­
ferent members of the gut microbiota can regulate 
larval growth. In one study, Lactobacillus plantarum 
was shown to modulate the target of rapamycin (Tor) 
pathway, a major sensor of the nutritional status of the 
cell, and to increase the release of insulin­like peptides, 
which increase the larval growth rate30. In the second 
study, Acetobacter  pomorum was identified as the 
member of the gut microbiota that has the greatest 
impact on host responses, ranging from growth 
and developmental time of larvae to body size and 
metabolism, through the impact of the bacterium on 
insulin signalling25. It was further demonstrated that 
the pyrrolo quinoline quinone­ dependent alcohol 
dehydrogenase (PQQ­ADH) activity of A. pomorum is 
capable of activating the insulin pathway, which leads 
to increased larval growth and body size. Notably, the 
reduced intestinal stem cell proliferation observed in 
axenic flies (see above) was also found to be mediated 
by decreased insulin signalling25, which modulates 
stem cell proliferation either cell autonomously32,33 or 
through the modulation of enterocyte growth34. The 
phenotypes of axenic flies can be rescued either by 
genetically enhancing insulin signalling or by supple­
menting the diet with acetic acid, a metabolic product of 
PQQ­ADH activity. However, this supplementation is 
effective only in the presence of the PQQ­ADH­mutant 
bacterium, suggesting that additional metabolic inputs 
from this bacterium are required25.
The antimicrobial response in the gut
Among the microorganisms that D.  melanogaster 
encounters and ingests, some have the potential to 
become pathogenic. To ensure its survival, D. melano­
gaster has developed a range of defence responses, both 
throughout the body and specifically in the gut. In con­
trast to the systemic response (BOX 2), which ensures the 
sterility of the body cavity and haemolymph, intestinal 
immune responses must tolerate the presence of the gut 
microbiota and dietary microorganisms while respond­
ing to and eliminating potential pathogens. This pre­
sents a conundrum, as the immune system has to either 
be able to distinguish between pathogens and benefi­
cial microorganisms, or at least be capable of adapting 
its response to the type of microorganisms present 
in the gut. Recent studies have shown that the gut 
immune response includes physical barriers that limit 
exposure to all microorganisms in the gut, as well 
as several tightly regulated inducible antimicrobial 
defences (FIG. 1).
Physical barriers: the peritrophic matrix, mucus and 
epithelial integrity. The peritrophic matrix is a mixed 
grid­like structure composed of chitin polymers and 
proteins such as peritrophins35,36. Studies with different 
insect species have suggested that the peritrophic matrix 
establishes a first line of defence by preventing contact 
between bacteria and the intestinal epithelium, and thus 
potentially blocking the injection of bacterial effectors 
by type III secretion systems, a common strategy used by 
enteropathogenic bacteria of mammals37. In addition, 
the peritrophic matrix acts as a sieve that restricts the 
passage of not only bacteria but also bacterial toxins 
and food particles36 (FIG. 1). Recently, a defensive role of 
the peritrophic matrix in D. melanogaster was shown 
through genetic manipulation38. Specifically, mutation 
of Crystallin, which encodes a chitin­binding protein 
expressed in the gut, was found to be associated with a 
decrease in the thickness of the peritrophic matrix and 
a higher susceptibility to infection with P. entomophila 
or to its pore­forming toxin, Monalysin (encoded by 
pseen3174). Ingestion of bacteria induced a higher level 
of expression of antibacterial peptides in Crystallin 
mutants, indicating that the peritrophic matrix might 
also restrict immune activation in the gut.
Box 2 | The systemic immune response
The direct introduction of bacteria or fungi into the body cavity of Drosophila 
melanogaster elicits multiple defence mechanisms, collectively termed the systemic 
immune response1. Early after injury, two reactions, melanization and coagulation, are 
induced to limit the spread of potential pathogens. The melanization reaction generates 
microbicidal reactive intermediates through the pro-phenol oxidase cascade, and the 
coagulation reaction forms a clot around the site of injury that can also trap the 
pathogen and block further invasion into the haemocoel. Circulating blood cells, called 
haemocytes, participate in clot formation through the release of secreted clotting 
factors, but their major contribution to immunity is to clear microorganisms through 
phagocytosis or to encapsulate larger foreign bodies. The last line of defence is the 
production of antimicrobial peptides (AMPs), mostly by the fat body (the analogue of 
the mammalian liver); these AMPs are released into the haemolymph. Two pathways are 
activated by the recognition of microorganisms; the immune deficiency (Imd) pathway 
is activated following the detection of products from Gram-negative bacteria 
(diaminopimelic acid-type peptidoglycan (DAP-PGN) by the membrane-bound 
peptidoglycan recognition protein LC (PGRP‑LC), and the Toll pathway is activated  
by the detection of fungi and Gram-positive, lysine-type peptidoglycan (Lys-PGN)-
containing bacteria by circulating receptors, which then initiate a proteolytic cascade 
leading to the activation of the cytokine Spatzle (Spz) and its recognition by the receptor 
Toll. For a complete review of the systemic immune response of the fly, see REF. 1.
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In vertebrates, the intestinal epithelium is sepa­
rated from the external environment by mucus layers 
composed of polysaccharides and proteins (mucins) 
that restrict bacteria to the lumen. The peritrophic 
matrix has a similar role in insects, but D. melanogaster 
also has a mucus layer that lines enterocytes along the 
midgut12. Although more than 30 D. melanogaster genes 
have been annotated as encoding mucin­like proteins39, 
the functional relevance of these genes or, more gener­
ally, of mucus in host defence in the D. melanogaster gut 
is not known. A transcriptomic analysis of guts from flies 
infected with E. carotovora subsp. carotovora 15 shows 
that many genes linked to peritrophic matrix metabo­
lism and mucus production are regulated by infection, 
suggesting that these two barriers are remodelled dur­
ing infection40. In addition, mutations affecting the 
strength of enterocyte septate junctions (for example, in 
the gene big bang) or the structure of the brush border 
(for example, in Myo61F, the gene encoding Myosin IB) 
cause higher susceptibility to bacterial infection, indicat­
ing that epithelial integrity contributes to resistance to 
bacterial pathogens41,42.
Imd signalling and AMP production. One of the best 
characterized responses of D. melanogaster to infection 
is the production of antimicrobial peptides (AMPs) to 
eliminate bacteria1. Two major signalling pathways, 
immune deficiency (Imd) and Toll, control the expres­
sion of AMPs in the body cavity1, but in the case of the 
midgut, AMP production is induced in response to Imd 
signalling40,43,44 (FIG. 1). Flies deficient for Imd activation 
are more susceptible to infection with pathogenic bacte­
ria such as S. marcescens and P. entomophila, suggesting 
that the Imd pathway has a fundamental role in intestinal 
defence15,45.
In the gut, the Imd pathway is activated by two 
pattern recognition receptors of the peptidoglycan recogni-
tion protein (PGRP) family: the membrane­bound cell 
surface receptor, PGRP­LC (which mainly acts in the 
foregut, the anterior midgut and the hindgut), and the 
cytoplasmic intracellular sensor, PGRP­LE (which func­
tions in the midgut)46,47 (FIG. 2). These receptors sense 
diaminopimelic acid (DAP)­type peptidoglycan, which 
is found in the cell wall of all Gram­negative bacteria 
and certain Gram­positive bacteria (bacilli)48–50. Both 
peptidoglycan monomers (also called tracheal cyto­
toxin (TCT)) and peptidoglycan polymers can activate 
the Imd pathway46,47,51 through binding to PGRP­LC 
and PGRP­LE in different gut compartments. The cell 
walls of Acetobacter and Lactobacillus spp., the dominant 
members of the D. melanogaster microbiota, contain 
DAP­type peptidoglycan, indicating that these species 
can be recognized by the gut immune response. In agree­
ment with this, the expression of AMPs is significantly 
reduced in the gut of axenic flies, indicating that the 
microbiota induces the Imd pathway in the gut16,17,52.
Several mechanisms ensure that the Imd pathway 
is not overactivated in response to pathogens or by the 
presence of the microbiota (FIG. 2). A first layer of con­
trol relies on the fact that bacterial sensing is achieved 
through the recognition of peptidoglycan. In Gram­
negative bacteria, this bacterial cell wall component is 
restricted to the periplasmic space, which is hidden by 
the outer layer of lipopolysaccharide and is therefore less 
accessible for detection by the host immune system53. In 
the case of the gut microbiota, the density of bacteria 
in the gut is significantly lower than that observed during 
experimental infections with pathogens16–18,54, so less 
immune­stimulating peptidoglycan would be present in 
the gut under normal conditions. As peptidoglycan frag­
ments are mostly released when the cell wall is remod­
elled during bacterial division, it is also possible that 
the microbiota proliferates more slowly in the gut than 
pathogens and that high rates of division would reflect 
an acute infection. The fact that the Imd pathway is more 
Figure 1 | Immune and repair mechanisms contribute to the resolution of infection.  
a | Physical barriers, such as the peritrophic matrix (a chitinous layer that separates 
epithelial cells from luminal contents), as well as the chemical conditions of the gut 
(low pH and the presence of digestive enzymes) provide the first barrier to infection. 
Microorganisms that are able to cross the peritrophic matrix then activate defence 
mechanisms, including the production of antimicrobial peptides (AMPs; through the 
immune deficiency (Imd) pathway) and reactive oxygen species (ROS; by Duox), which 
limit the growth of pathogens. In some cases, the host response, especially the production 
of ROS, has secondary consequences on the host, eliciting delamination of enterocytes 
from the epithelium. This damage is compensated for by the induction of epithelial 
renewal: the secretion of growth factors from enterocytes promotes the differentiation 
of quiescent enteroblasts (Ebs), to immediately repair damage, and the division of 
intestinal stem cells (ISCs), to fully replace damaged cells and return to homeostatic 
conditions. b | An electron micrograph of the fly gut, showing the peritrophic matrix (PM). 
c | A histology section showing delamination of an enterocyte. d | A live-cell micrograph 
showing proliferation of ISCs in a fly line containing an inducible GFP gene under the 
control of the upstream activation sequence (UAS) enhancer, and Gal4 (which drives 
expression from the UAS enhancer) coupled with escargot (esg), a gene that is expressed 
specifically in progenitors (ISCs and enteroblasts). Part b image is reproduced, with 
permission, from REF. 116 © (2000) Elsevier. Part c image is reproduced, with permission, 
from REF. 54 © (2010) BioMed Central Ltd. Part d image is reproduced, with 
permission, from REF. 16 © (2009) Cold Spring Harbor Laboratory Press.
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highly induced by peptidoglycan monomers (TCT) 
allows an additional level of discrimination, as TCT 
is found in Gram­negative bacteria, but not in DAP­
type Gram­positive bacteria, such as Lactobacillus spp., 
which tend to be more consistently associated with flies 
and are present at higher numbers in the gut than the 
Gram­negative, TCT­containing Acetobacter spp.21,22. 
Furthermore, the predominant role of the intracellu­
lar peptidoglycan receptor, PGRP­LE, in activating the 
Imd pathway in the midgut — which is the region most 
accessible to bacterial compounds from the gut lumen 
— could ensure a lower level of immune reactivity in 
normal conditions46,47.
A second layer of control is provided by the expres­
sion of negative regulators that downregulate the Imd 
pathway at virtually all levels of the cascade. These 
regulators are often themselves activated by the Imd 
pathway, establishing a negative feedback loop that 
adjusts the amplitude of the immune response to both 
the gut microbiota and pathogens. One class of negative 
regulators is the amidase PGRPs (PGRP­LB, PGRP­SB1, 
PGRP­SB2, PGRP­SC1a, PGRP­SC1b and PGRP­SC2), 
which cleave peptidoglycan and reduce the levels of 
immunostimulatory compounds in the gut lumen51,55–57. 
Among these, PGRP­LB has a predominant role in the 
gut to downregulate the Imd pathway51,58. In addition, 
PGRP­LB and, to a lesser extent, the PGRP­SC pro­
teins scavenge immunostimulatory molecules in the 
gut lumen, thereby limiting their passage into the body 
cavity and preventing aberrant activation of the systemic 
immune response to bacteria that have not crossed the 
gut barrier51,58. Another class of negative regulators 
Figure 2 | Regulation of the immune deficiency pathway in the Drosophila melanogaster midgut. The immune 
deficiency (Imd) pathway is a key component of the response to infection in the fly gut. This pathway is basally activated  
by the gut microbiota and ingested microorganisms, and strongly induced by microbial infection. In addition, it has a 
demonstrated regional specificity depending on the tissue responding to infection (cardia and anterior midgut (left) versus 
posterior midgut (right)). The pathway is activated by the recognition of diaminopimelic acid-type peptidoglycan (DAP) by 
the cell surface-expressed peptidoglycan recognition protein LC (PGRP-LC; which has a predominant role in the anterior 
midgut, notably the ectodermal cardia) and the recognition of DAP monomers (also called tracheal cytotoxin (TCT)) by  
the intracellular receptor, PGRP-LE (which has a predominant role in the endodermal posterior midgut). Activation of the 
receptors triggers a signalling cascade that ultimately results in the production of antimicrobial peptides (AMPs). Multiple 
negative regulators of the Imd pathway have been identified that decrease the amount of immune-reactive compounds  
(as in the case of PGRP-LB), decrease the activity of the receptor (as in the case of PGRP-LF and Pirk (poor Imd response 
upon knock-in)) or modulate the transcriptional response of the transcription factor Relish (Rel) (as in the case of Caudal). 
Bold lines indicate the dominant pathways in each region of the gut. IKKβ, inhibitor of NF-κB kinase subunit-β (also known 
as Ird5); IKKγ, IKK subunit-γ (also known as Key); Tak1, transforming growth factor-β-activated kinase 1.
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targets intracellular components of the Imd pathway. 
The gene pirk (poor Imd response upon knock­in), which 
is induced in response to Imd signalling, encodes a pro­
tein that relocalizes PGRP­LC from the cell membrane 
to an intracellular compartment, thus disrupting its 
interaction with Imd and limiting Imd signalling52,59,60. 
Similarly, PGRP­LF, a transmembrane receptor with two 
external PGRP domains but no intracellular signalling 
domain, binds PGRP­LC and decreases Imd signalling, 
probably by sequestering a fraction of the PGRP­LC 
isoforms61,62. In addition, multiple proteins (including 
the Cullin 1 (also known as Lin19)–SkpA complex, 
USP36 (also known as Scny), Cylindromatosis, POSH, 
Defence repressor 1 (Dnr1) and Caspar) have been 
shown to decrease Imd signalling by modulating dif­
ferent steps of the signalling pathway, for example by 
promoting ubiquitylation and subsequent degradation 
of Imd pathway components63,64. These multiple layers of 
negative regulation allow the host to match the level 
of immune induction to the level of immune stimulus, 
thus avoiding chronic activation of the Imd pathway by 
the gut microbiota or a damaging immune response to 
pathogens. Although there is no evidence for a specific 
dialogue between the gut microbiota and the host, the 
gut immune system in the fly affords an adapted and 
proportionate response to control both microbiota 
and pathogens and to avoid deleterious immune 
induction.
Another layer of control is provided by the compart­
mentalization of the antimicrobial response along the 
gut. Although the Imd pathway is activated all along 
the gut in response to bacteria, AMPs are differentially 
produced along the digestive tract12,40,43. This patterned 
AMP expression is mediated by regionalized transcrip­
tion factors that can restrict AMP expression to specific 
segments of the gut. For instance, the homeobox protein 
Caudal is expressed in the posterior midgut and blocks 
the expression of AMP­encoding genes, but does not 
affect PGRP­LB expression in this region17. Thus, Imd 
pathway effectors, such as AMPs, and regulators, such 
as PGRP­LB, can have distinct patterns of regulation in 
different gut regions. This indicates that AMP expression 
along the gut is regulated both by inducible signals from 
the Imd pathway and by regional cues.
Production of ROS in response to microorganisms. 
Surprisingly, flies that are deficient for the Imd path­
way, which are unable to activate an AMP response, still 
survive oral infection with most bacteria. This suggests 
that complementary immune mechanisms are active 
in the gut44. Indeed, ingestion of E. carotovora subsp. 
carotovora 15 induces the production of reactive oxygen 
species (ROS) in the gut65 (FIGS 1,3). RNAi studies indicate 
that ROS in the D. melanogaster gut are produced by the 
NADPH oxidase Duox65,66. This enzyme has been pro­
posed to eliminate bacteria through the direct bactericidal 
effect of ROS, which cause damage to DNA, RNA and 
proteins, and promote the oxidative degradation of lipids 
in cell membranes. However, the possibility that Duox has 
additional roles cannot be excluded. Along these lines, 
studies carried out in the mosquito Anopheles gambiae 
have suggested that the ROS­generating activity of 
Duox modulates peritrophic matrix sclerotization, which 
reduces gut permeability and induction of the immune 
response67. This role could be conserved in D. melano­
gaster, as Duox has recently been shown to contribute 
to stabilization of the cuticular structure of the wing68. 
Finally, ROS generated by Duox have been shown to 
regulate the activation of wound healing responses, sug­
gesting that in addition to a bactericidal role, ROS act as 
signalling molecules to induce repair responses or other 
homeostatic pathways69,70.
Both the expression and ROS­producing activity of 
Duox are upregulated by the detection of microorgan­
isms71,72. Duox­mediated ROS production is directly 
increased following the release of intracellular calcium 
from the ER71. Biochemical studies have shown that, 
on the detection of bacteria in the lumen, the adaptor 
guanine­ nucleotide­binding protein q subunit­α (Gαq) 
and phospholipase Cβ (PLCβ; also known as NorpA) 
induce the synthesis of inositol­3­phosphate, which 
mobilizes intracellular calcium, ultimately leading 
to Duox activation71. On infection, the transcription 
of Duox is also increased through the activation of a 
Mekk1–p38a (also known as Mpk2) mitogen­activated 
protein kinase (MAPK) pathway, which activates the 
Duox­targeting transcription factor Atf2 (REF. 72). Of 
note, flies bearing mutations in p38a and p38b are 
susceptible to oral microbial infection, illustrating the 
importance of stress signalling pathways in the gut73. In 
the case of Duox, Mekk1–p38a activation depends on 
both the recognition of peptidoglycan by the Imd path­
way and the recognition of uracil, which is proposed to 
be released by pathogenic bacteria in the gut and prob­
ably activates a G protein­coupled receptor (GPCR) 
upstream of Gαq–PLCβ
72,74. These results suggest that 
D. melanogaster can detect infection through the rec­
ognition of at least two different types of microbial 
products in the gut: peptidoglycan and uracil.
Duox is also basally activated by the gut microbiota 
and dietary yeast species. In the presence of the gut 
microbiota, the activity of the p38 MAPKs is buffered 
by MAPK phosphatase 3 (Mkp3), which shuts down 
Duox activity72. Mkp3 is expressed in a PLCβ­ and 
Calcineurin B­dependent manner, indicating that the 
same pathway that is responsible for Duox induction 
during infection shuts down Duox activity in basal con­
ditions. Thus, like the Imd response, Duox activity is 
induced according to the level of stimulus and is tightly 
regulated to reduce excessive activation by the gut micro­
biota. Deletion of Mkp3 leads to a shorter fly lifespan 
and increased apoptosis in the gut. This phenotype is 
fully suppressed by the knockdown of Duox, suggesting 
that flies lacking Mkp3 die owing to excessive ROS lev­
els72. Interestingly, uracil is released by pathogenic bacte­
ria such as E. carotovora subsp. carotovora 15 and by the 
microbiota­derived pathobiont Gluconobacter morbifer 
(see below) at higher quantities than by other indige­
nous microorganisms74. This suggests that the amount 
of uracil released by bacteria allows the fly to differen­
tiate between benign and pathogenic microorganisms 
in the gut.
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Other defence mechanisms. Although Duox and the 
Imd pathway provide two complementary lines of 
defence44, they are not the only mechanisms that con­
trol microorganisms in the fly gut. In addition to AMPs 
regulated by the Imd pathway, a group of AMPs known 
as Drosomycin­like peptides (Drsl2, Drsl3 and DrlI4) is 
induced in the anterior part of the gut, under the con­
trol of the JAK–STAT pathway40,75, and is thought to 
have antifungal but not antibacterial activity76,77 (FIG. 4). 
The expression of Drosomycin­like peptides depends 
on the JAK–STAT ligands Upd2 and Upd3, which are 
released by the epithelium following damage40,75 (see 
below), suggesting that the production of antifungal 
peptides in the gut is activated on intestinal damage 
rather than in response to microbial products, as occurs 
with antibacterial peptides.
Recently, genes involved in the Toll pathway and 
melanization were shown to be expressed in the foregut 
and hindgut, which are the ectodermal segments of 
the digestive tract15 (BOX 1), but whether or how these 
genes contribute to host defence is not known. Likewise, 
despite the fact that a population of phagocytes has been 
found to reside in the larval cardia, there is no evidence 
of the involvement of blood cells in the gut response to 
ingested microorganisms78.
Gut epithelium renewal on infection
Recent studies have shown that an efficient and rapid 
recovery from a bacterial infection is possible only when 
the immune response is coordinated with epithelial 
renewal to repair the damage caused by infection40,79–81. 
This is in line with the notion that the ability to survive 
an infection relies not only on resistance mechanisms 
that eliminate the pathogen but also on tolerance mecha­
nisms (such as gut repair) that increase the capacity of 
the host to endure the infection82.
Figure 3 | Regulation of reactive oxygen species production in the Drosophila melanogaster midgut. The production 
of reactive oxygen species (ROS) is another core component of the immune response in the gut of the fly. As with the immune 
deficiency (Imd) pathway, the ROS response is basally activated by the gut microbiota and ingested microorganisms, and 
strongly induced by microbial infection. Microbially derived uracil triggers the adaptor guanine-nucleotide-binding protein q 
subunit-α (Gα
q
) and phospholipase Cβ (PLCβ) to induce the synthesis of inositol-3-phosphate, which in turn mediates the 
release of intracellular calcium and the transcription of the oxidase-encoding gene Duox. Duox transcription can also be 
induced by the p38 mitogen-activated protein kinase (MAPK) pathway and the transcription factor Atf2. The Duox pathway 
is also tightly regulated under basal conditions, when the p38-mediated transcription of Duox is downregulated by MAPK 
phosphatase 3 (Mkp3); Mkp3 transcription is induced under basal conditions by PLCβ and Calcineurin B (CanB). GPCR,  
G protein-coupled receptor; IKKβ, inhibitor of NF-κB kinase subunit-β (also known as Ird5); IKKγ, IKK subunit-γ (also known 
as Key); Mekk1, MAPK and ERK kinase kinase 1; MKK3, MAPK kinase 3 (also known as Lic); Tak1, transforming growth 
factor-β-activated kinase 1.
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Several studies have shown that ingestion of bacte­
rial pathogens damages the epithelium, resulting in the 
death of intestinal cells16,40,54,80,81,83. This damage is caused 
both by bacterial toxins that directly target the epithe­
lium and by the immune response itself (for example, 
the ROS burst caused by Duox activation)16. Gut homeo­
stasis is maintained because the loss of enterocytes is 
compensated for by the activation of intestinal stem 
cells, which proliferate and differentiate into new entero­
cytes to rebuild the gut40,54,80 (FIG. 4). Genetic studies 
have shown that this response depends on induction of 
the Wingless, JAK–STAT and Epidermal growth factor 
receptor (Egfr) pathways in progenitor cells, which stimu­
lates their proliferation and increases their differentiation 
into enterocytes16,54,80,84–86. Indeed, when the progenitor 
cells are mutated for the JAK–STAT or Egfr pathways, 
the mutant flies die because they are unable to repair 
the damage associated with infection16,75,80. JAK–STAT 
and Egfr signalling is activated by the release of 
JAK–STAT ligands (Upd2 and Upd3) or growth factors 
(epidermal growth factors and Wingless), respectively, 
by stressed enterocytes and activated progenitors, estab­
lishing a compensatory homeostatic loop16,40,54,75,80,84,85. 
Interestingly, visceral muscles that surround the epi­
thelium contribute to this response by producing the 
epidermal growth factor Vein in response to JAK–STAT 
activation54,84,85,87.
A key aim of research in this field is to decipher the 
signals that lead to the production of early­secreted 
factors, as such factors are the first line of regulation 
for epithelial renewal. Initial studies have shown that 
the induction of Upd3 depends on the activation of 
both stress kinases, such as JNK (also known as Bsk), 
and pathways that sense epithelial integrity, such as the 
Hippo pathway80,88–91. However, knockdown of JNK does 
not fully block Upd3 induction, suggesting that other 
regulators exist80.
In basal conditions, the gut microbiota also promotes 
epithelial renewal, but to a lesser extent than infectious 
bacteria, suggesting that the microbiota causes less 
stress and damage to the gut than infectious bacteria. 
Interestingly, the level of intestinal stem cell activity 
seems to be a good indicator of gut health, and patholo­
gies of the gut are often associated with either a blockage 
to or chronic activation of stem cell activity.
Ruptures in gut homeostasis
Rupture of gut homeostasis by the microbiota. Although 
D. melanogaster immune responses are tightly controlled 
in the absence of infection, these responses can some­
times become dysregulated and lead to situations in 
which the gut microbiota contributes to high immune 
activation and loss of gut homeostasis. Specifically, loss 
of gut homeostasis is observed in flies carrying muta­
tions that alter gut compartmentalization. For instance, 
disruption of the transcription factor Caudal in the 
posterior midgut is associated with increased produc­
tion of AMPs, which alters the composition of the gut 
microbiota and promotes the dominance of an otherwise 
minor member, G. morbifer17. The dysbiosis induced by 
caudal mutation causes damage to the gut and results 
in a loss of intestinal homeostasis, increased cell death 
and reduced lifespan. However, this situation does not 
appear to be specific to Caudal, as chronic expression of 
AMPs and high epithelial cell turnover are observed in 
several mutants in which gut organization is altered12. 
Together, these results indicate that gut structure and its 
organization into regions with distinct immune and 
metabolic properties are essential to the interactions of 
D. melanogaster with microorganisms.
Along these lines, there is evidence that the gut micro­
biota has a role in the initiation and progression of intes­
tinal age­related disease. Old flies show gut dysplasia, 
accumulate undifferentiated intestinal cell progenitors 
and have a high rate of intestinal stem cell prolifera­
tion92,93, all of which are associated with a loss in intes­
tinal barrier integrity94. This aberrant epithelial renewal 
results from chronic activation of the stress­responsive 
Figure 4 | Epithelial renewal establishes a homeostatic loop required to tolerate 
infection. A major factor in the likelihood of a host surviving pathogen infection is the 
ability of that host to repair damage. In response to ingestion of the non-lethal pathogen 
Erwinia carotovora subsp. carotovora 15, stressed enterocytes (Ecs) delaminate from the 
epithelium but are replaced by newly synthesized cells. New enterocytes originate from 
the quick differentiation of progenitor cells called enteroblasts (Ebs) and the induced 
proliferation of intestinal stem cells (ISCs). One of the initial events in this process is the 
expression and release of the JAK–STAT ligand Upd3 and the epidermal growth factor 
Keren by stressed enterocytes, which is thought to be induced through signalling from 
the JNK and Hippo pathways. Induction of the JAK–STAT pathway in progenitors 
increases their differentiation and promotes the synthesis of Upd3 and the epidermal 
growth factor Spitz. In addition, JAK–STAT activation in the surrounding visceral muscles 
promotes the synthesis of the epidermal growth factor ligand Vein. Together, these 
factors induce the Epidermal growth factor receptor (Egfr) pathway in ISCs to increase 
the ISC proliferation rate. By contrast, the high epithelial stress that is inflicted by ingested 
Pseudomonas entomophila decreases global translation in enterocytes by inducing the 
kinase Gcn2 and decreasing target of rapamycin (Tor) signalling. This decrease in 
translation results in a lack of epithelial repair and the subsequent death of the fly. This 
overwhelming stress response is dependent on the high levels of reactive oxygen species 
(ROS) that are generated in the gut in response to the pathogen, as well as the bacterial 
production of pore-forming toxins.
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kinase JNK and increased levels of ROS in the gut93. 
Interestingly, old flies also have higher bacterial loads 
in their gut, and axenic flies display attenuated intes­
tinal dysplasia, suggesting that bacteria contribute to 
the disorganization of the gut in aged flies, possibly by 
modulating epithelial turnover16. Furthermore, intesti­
nal dysplasia is associated with gut barrier dysfunction 
and higher expression of immune genes by the fat body 
in old flies94, suggesting that the interaction between the 
microbiota and the intestine influences the lifespan of 
D. melanogaster.
Finally, dysregulation of the Imd pathway can also 
disrupt gut homeostasis. Flies lacking multiple negative 
regulators of the Imd pathway (for example, PGRP­LB 
and Pims) have a shorter lifespan owing to the con­
tinuous stimulation of the Imd pathway by the gut 
microbiota58. Collectively, these studies highlight the 
fact that diverse factors which lead to dysbiosis induce 
pathologies with similar hallmarks: higher stem cell 
activity, derepression of immune genes and altered 
lifespan. Future work should decipher the causal links 
between these factors and how they contribute to 
organismal health.
Disruption of gut homeostasis by pathogens. As men­
tioned above, to survive infection by a pathogen, the 
host must activate immune defences, as well as repair 
mechanisms that maintain tissue integrity. However, in 
some circumstances these mechanisms fail, leading to a 
rupture of intestinal homeostasis and, eventually, death 
of the host.
One mechanism by which pathogens can prevent the 
re­establishment of homeostasis is through excessive 
activation of stress­induced pathways (FIG. 4). This mech­
anism was recently shown to underlie the pathogenesis 
induced by P. entomophila, a newly described bacte­
rium95 that is lethal to multiple insect species14. In adult 
D. melanogaster, infection with P. entomophila leads to 
overactivation of the kinase Gcn2 and inhibition of the 
Tor pathway by AMP­activated protein kinase (AMPK; 
also known as SNF1A). These stress­responsive path­
ways decrease protein translation rates, thereby blocking 
the synthesis of immune effectors and of growth factors 
that regulate epithelial repair 96. As a consequence, 
epithelial renewal is disrupted, and the intestinal dam­
age caused by infection cannot be repaired, leading to 
fly death96. Gcn2 and AMPK are activated by a variety 
of stresses, such as starvation and oxidative stress, and 
translation inhibition is generally proposed to be a benefi­
cial stress response that allows a cell to pause protein 
translation and instead use its resources to repair dam­
age97,98. Accordingly, this response is protective following 
infection with non­lethal pathogens such as E. caroto­
vora subsp. carotovora 15 and helps the host to survive 
infection96. Thus, bacterial pathogenesis can occur 
through the excessive activation of stress­responsive 
pathways that normally protect the host. Therefore, 
one feature that might differentiate lethal and non­
lethal entomopathogens is the severity of damage that 
the pathogen can inflict on the host, and whether 
that damage reaches a threshold which compromises 
host responses. In the case of P. entomophila, damage 
is caused by secreted virulence factors such as the pore­
forming toxin Monalysin99 and by an excessive produc­
tion of ROS by the host96. Interestingly, infection with 
P. entomophila is also associated with a strong activation 
of the Imd pathway in the fat body45. It remains to be 
determined whether this systemic response is a direct 
consequence of gut damage, which would allow passage 
of bacterial compounds into the haemolymph, or a sec­
ondary consequence of the translation blockage, which 
would result in decreased synthesis of negative regula­
tors (such as Pirk and PGRP­LB) that normally restrict 
the immune response to the gut51,96.
Other bacteria are lethal because they cross the gut 
barrier or form biofilms in the gut. For instance, the mech­
anisms of infection of two other pathogens, S. marcescens 
subsp. marcescens str. Db11 and Pseudomonas aeruginosa, 
are clearly distinct from that of P.  entomophila, as 
oral infection with these bacteria involves crossing 
of the gut epithelium and systemic infection. When 
ingested, S. marcescens persists in the gut and induces 
the local production of AMPs, after which it crosses the 
intestinal barrier to reach the haemocoel15. However, it 
is unclear where S. marcescens proliferates; moreover, 
the associated bacteraemia, which kills the fly in 
4–8 days, does not elicit a systemic immune response15. 
It has been proposed that S. marcescens is not detected 
by the fly immune system because there is a low release 
of peptidoglycan into the haemolymph15. Both the local 
production of AMPs in the gut and the phagocytosis of 
S. marcescens in the haemolymph contribute to the host 
response to this bacterium15,100,101. A pangenomic RNAi 
screen carried out in D. melanogaster suggests that, as 
in the case of P. entomophila and E. carotovora, the host 
response to S. marcescens encompasses both immune and 
repair mechanisms79. P. aeruginosa also induces entero­
cyte death on ingestion and can cross the gut barrier 
of D. melanogaster83,102.
Finally, studies using the human pathogen Vibrio 
cholerae have shown that the ability of a pathogen to 
form a biofilm can be lethal to D. melanogaster. Contrary 
to its effect on mammals, ingestion of cholera toxin 
alone does not kill D. melanogaster 103. However, when 
the bacterium itself is ingested, the gut environment 
activates the production of V. cholera polysaccharides 
that allow bacterial colonization of the hindgut, which 
is necessary for lethality104. Surprisingly, Imd­deficient 
flies are more resistant to infection with V. cholerae103, 
suggesting that the immune response contributes to 
V. cholerae pathogenesis.
Concluding remarks
Much recent research has focussed on the gut­associated 
bacteria of D. melanogaster and on oral models of infec­
tion for the fruitfly, and the findings from this research 
have highlighted the fact that gut epithelial responses to 
microorganisms are complex and diverse, whether those 
organisms be benign, beneficial or pathogenic. To date, 
the only factor that distinguishes the gut microbiota from 
pathogens in D. melanogaster is the quantity of uracil 
released in the gut. Instead, regulatory mechanisms 
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such as those downregulating the Imd pathway ensure 
an appropriate level of immune reactivity in the gut 
to accommodate the presence of the microbiota and 
dietary microorganisms (which have numerous effects 
on host physiology) while allowing effective elimination 
of pathogens.
Although the role of AMPs and ROS in the gut 
immune response is well established, additional mecha­
nisms are likely to be involved. For instance, most studies 
have dissected the response to Gram­negative bacteria, 
and it remains unknown whether the gut mounts spe­
cific responses to Gram­positive bacteria, which contain 
lysine­type peptidoglycan, or to fungi, protozoa and 
viruses. In addition, a range of gut physiological func­
tions might also limit the effects of ingested microorgan­
isms. For example, the low pH of specific gut regions, as 
well as digestive enzymes such as lysozyme and proteases, 
might have antimicrobial effects. Even gut peristalsis 
might assist by moving ingested pathogens into regions 
that are less hospitable (acidic regions or areas of higher 
AMPs concentration) or eliminating them by excretion. 
As observed in other insects, some ingested pathogens 
can cause a malaise that is associated with the cessation 
of feeding105. The contribution of this response to disease 
pathology and the underlying molecular mechanisms 
that govern this response are not completely understood. 
However, the malaise response suggests that there is a 
sort of communication between the gut and the nervous 
system that remains to be characterized. The recent 
demonstration that flies have a dedicated nervous circuit 
to detect the volatile compound geosmin, which is pro­
duced by mould fungi and actinobacteria, indicates the 
ability of flies to identify potential pathogens106. Thus, 
pathogen detection and avoidance might have an impor­
tant role in the survival of D. melanogaster to pathogens, 
as has been shown in C. elegans107.
Another important lesson from studies on the 
D. melanogaster gut response to bacterial infection is 
the importance of the stress response and repair mecha­
nisms that maintain tissue integrity40,73,80,96. How stress 
and repair programmes are integrated with the immune 
response remains largely unknown and promises to be 
a rich area of study. As illustrated above, studies using 
pathogenic bacteria and the oral route of infection have 
begun to identify common virulence mechanisms that 
can disrupt gut homeostasis. Some of these mechanisms 
are likely to be used by other entomopathogenic bacte­
ria, and their investigation in D. melanogaster could help 
decipher how bacteria evolve as entomopathogens. For 
instance, the implication of Monalysin in P. entomophila 
virulence, together with the well­characterized action of 
crystal toxins from the most widely used organic pes­
ticide, Bacillus thuringiensis108, highlights the key role 
of pore­forming toxins in bacterium­mediated patho­
genesis of insects. These toxins could represent an adap­
tation to the insect gut structure, as their action does not 
require direct contact between the bacterium and host 
cells and because they can reach intestinal cells despite 
being limited by the peritrophic matrix.
Many aspects of the D. melanogaster gut response are 
likely to be relevant to other host organisms, including 
mammals. For instance, mucosal defences in mice 
also rely on the production of antimicrobial peptides 
and ROS109. A recent report indicates that Salmonella 
enterica subsp. enterica serovar Typhimurium infection 
in mice increases the level of stem cell proliferation, 
suggesting that, similarly to in the D. melanogaster gut, 
both immune and repair mechanisms contribute to 
host defence in the mammalian gut110,111. These studies 
suggest that D. melanogaster and its powerful genetics 
can highlight some important facets of intestinal 
homeostasis that are relevant to vertebrates and could 
provide insights into the molecular determinants that 
link chronic infection, stem cell activity and cancers of 
epithelial origin. Thus, studies on the D. melanogaster 
gut response to microorganisms should not only illu­
minate many facets of gut–microorganism interactions 
that are conserved in other insects, including insect 
pests and vectors affecting human health, but also 
increase our understanding of the general mechanisms 
used by animals to maintain intestinal homeostasis in a 
microbial world.
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